Snijder, Michelle I. J. http://orcid.org/0000-0001-9630-6984
Dietz, Claudine
van Andel, Mieke
Ruiter, Emilie L. M.
Buitelaar, Jan K.
Oosterling, Iris J.
Funding for this research was provided by:
Korczak Foundation (Grant No. 2018-01)
Article History
Received: 7 March 2022
Accepted: 29 October 2022
First Online: 8 December 2022
Declarations
:
: The study is conducted according to the principles of the Declaration of Helsinki (version 64th, October 2013) and in accordance with the Medical Research Involving Human Subjects Act (WMO) and other guidelines, regulations and acts. The study is approved by the medical ethics Committee on Research involving Human Subjects (CCMO, Arnhem-Nijmegen) and is registered under number 2018–4309.
: Written informed consent regarding participation and publication from all parents or guardians for participants under 16 years will be obtained during the randomized controlled trial.
: Jan K Buitelaar has been in the past 3 years a consultant to / member of advisory board of / and/or speaker for Takeda/Shire, Roche, Medice, Angelini, Janssen, and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties.